Network origin in Jean-Marc Ferrier first degree
Entity | Entity type | Industry | |
---|---|---|---|
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin.
34
| Non-Profit Organization | Miscellaneous Commercial Services | 34 |
Graftys SA
Graftys SA Medical SpecialtiesHealth Technology Graftys SA designs, manufactures and markets calcium phosphate-based synthetic bone substitutes to the global orthopedic and dental surgery markets. Its research and development projects include injectable and resorbable synthetic bone substitutes, biological repair of cartilage and of the spine, as well as bone substitutes combined with pharmaceutical agents. The company was founded by Jean Marc Ferrier, Alain Valet, Jean-Michel Bouler and Aurélien Valet in September 2005 and is headquartered in Aix-en-Provence, France.
13
| Holding Company | Medical Specialties | 13 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jean-Marc Ferrier via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
CELLECTIS S.A. | Pharmaceuticals: Major | Founder Director of Finance/CFO Chairman | |
Elaia Partners SAS
Elaia Partners SAS Investment ManagersFinance Elaia Partners SAS (Elaia) is an independent French private equity boutique which was founded in 2002. Named after the Greek word for olive tree, the symbol of resilience, longevity and prosperity, Elaia focuses on software technology companies. The firm is headquartered in Paris and manages Elaia Ventures, a French FCPR fund backed by financial institutions, industrial investors and family offices. | Investment Managers | Private Equity Investor Private Equity Investor | |
TXCELL | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
Ecole Polytechnique | College/University | Undergraduate Degree Undergraduate Degree | |
Healthtech For Care | Corporate Officer/Principal Chairman | ||
CORETECH 5 | Agricultural Commodities/Milling | Director/Board Member Director/Board Member | |
ACTICOR BIOTECH SAS | Biotechnology | Founder Director/Board Member | |
Theravectys SAS
Theravectys SAS BiotechnologyHealth Technology Theravectys SAS provides biotechnology research services. It is working on the development of a therapeutic vaccine against HIV. The company was founded on May 17, 2005 and is headquartered in Paris, France. | Biotechnology | Chief Executive Officer Director/Board Member | |
Apaxen SA
Apaxen SA BiotechnologyHealth Technology Apaxen SA is a privately-held biotechnology company that was founded in 2018 and is based in an undisclosed location. The Belgian company has raised €5.4 million in equity and grant funding since its A round in 2019. Apaxen is focused on developing a pipeline of NLRP3 inflammasome inhibitors with a novel mechanism of action for the treatment of chronic inflammatory and autoimmune diseases. The company's clinical candidate, MFC-1040, is an orally bioavailable and selective small molecule NLRP3 inflammasome inhibitor that has demonstrated efficacy in multiple animal models of chronic inflammatory disease and pulmonary fibrosis. The company's team combines the experience required for clinical development of its products and is supported by a world-class team of scientific advisors. Apaxen has a pipeline of products at discovery and preclinical stages of development for the treatment of diseases associated with chronic inflammation that depend on NLRP3 inflammasome activation. The company was founded in 2018 by Gael Jalce, Enrico Jose Adolfo Bastianelli, and Bart Wuurman has been the CEO of the company since 2020. | Biotechnology | Founder Director/Board Member | |
VALERIO THERAPEUTICS | Pharmaceuticals: Major | Founder Chief Executive Officer | |
Tc Land Expression SA
Tc Land Expression SA Miscellaneous Commercial ServicesCommercial Services Tc Land Expression SA operates as a molecular diagnostic company. It focuses on the development and commercialisation of tests aimed at monitoring patients with immunological conditions. The firm specializes in the area of organ transplantation and immune mediated disorders. Its development programs encompass RA-INF-Dx, IMD Dx2, IMD Dx3, and L-TolX. The company was founded by Marina Guillet and Alain Huriez in November 2002 and is headquartered in Huningue, France. | Miscellaneous Commercial Services | Director/Board Member Chief Operating Officer | |
Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree Doctorate Degree | |
Hemarina SA
Hemarina SA BiotechnologyHealth Technology Hemarina SA operates as a biotechnology company which develops oxygen carrier for therapeutic and industrial applications. It offers organ preservation, wound healing, hemoglobin oxygen-carrier, cell culture and bioproduction and other perspective products. The company was founded by Franck Zal, Elisabeth Leize, Morgane Rousselot and Laurent Meijer on March 26, 2007 and is headquartered in Morlaix, France. | Biotechnology | Chairman Chief Executive Officer | |
École Normale Supérieure | College/University | Doctorate Degree Graduate Degree | |
Olgram SAS
Olgram SAS Miscellaneous Commercial ServicesCommercial Services Olgram SAS provides scientific research and development services. The company is based in Brehan, France. The French company was founded by Hervé Balusson, Maryvonne Hiance, Karim Asehnoune, Pi Nyvall Collén, Pierre Rocheteau. Pierre Rocheteau has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder Founder | |
Atlanpole Biotherapies
Atlanpole Biotherapies Miscellaneous Commercial ServicesCommercial Services Atlanpole Biotherapies provides immunotherapy, regenerative medicine, and radio pharmacy bio cluster services. The company is based in Nantes, France. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
LFB Biotechnologies SASU
LFB Biotechnologies SASU BiotechnologyHealth Technology LFB Biotechnologies SASU provides plasma-derived medicinal products. The firm undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The company was founded on September 21, 2006 and is headquartered in Courtaboeuf, France. | Biotechnology | Chief Executive Officer Chief Operating Officer | |
THERAVET SA | Miscellaneous Commercial Services | Founder Director/Board Member | |
REVO BIOLOGICS INC | Biotechnology | Director/Board Member Director/Board Member | |
Biologics 4 Life SAS
Biologics 4 Life SAS Pharmaceuticals: MajorHealth Technology Part of Graftys SA, Biologics 4 Life SAS develops injectable biomaterials to treat and prevent fractures caused by osteoporosis. The company is based in Jouques, France. The French company was founded in 2018 by Aurelien Valet, Alain Valet, Sébastien Genesta. Biologics 4 Life was acquired by Graftys SA on November 08, 2021. | Pharmaceuticals: Major | Founder Founder | |
THERADIAG | Medical Specialties | Chairman Chief Executive Officer | |
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
CYTOO SA
CYTOO SA Medical SpecialtiesHealth Technology CYTOO SA operates as a contract research organization which develops physiological cell-based assays. It focuses on developing, manufacturing, and commercializing new technologies for cell analysis for life sciences research community. The company has offices in Bethesda and Grenoble. The company was founded by François Chatelain, Alexandra Fuchs and Jacques Lewiner in 2008 and is headquartered in Grenoble, France. | Medical Specialties | Director/Board Member Director/Board Member | |
Amolyt Pharma SAS
Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Institut Pasteur
Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris. | Investment Trusts/Mutual Funds | Director/Board Member Corporate Officer/Principal | |
Horama SA
Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Biotechnology | Chief Executive Officer Director/Board Member | |
Natixis SA (Broker)
Natixis SA (Broker) Investment Banks/BrokersFinance Natixis SA (Broker) is the securities brokerage division of Natixis SA (EPA: KN), a corporate and investment bank headquartered in Paris, France. They are ultimately owned by BCPE SA. The firm provides full spectrum of broking services to various investors. | Investment Banks/Brokers | Analyst-Equity | |
ACG Management SAS
ACG Management SAS Investment ManagersFinance ACG Management SAS (ACG) is the private equity subsidiary of Vivéris Holding SAS in France. The firm was formerly known as Vivéris Management SAS, established in 2000, and became ACG Management in 2014. Based in Marseille, with additional offices in Ajaccio and St. Denis de la Réunion and subsidiaries in New Caledonia and Tunisia, ACG is a multi-regional firm which provides technology venture capital, development capital, capital transmission and LBO services as well as a range of investment vehicles, including FCPIs, FIPs and FCPRs for institutional investors. | Investment Managers | Private Equity Investor | |
GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member | |
SENSORION | Pharmaceuticals: Major | Director/Board Member | |
Bryan, Garnier & Co Ltd. (France) | Investment Banks/Brokers | Director of Research - Equity | |
Laboratoire Français du Fractionnement et des Biotechnologies
Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | Biotechnology | Chief Executive Officer | |
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Private Equity Investor | |
ODDO BHF SE
ODDO BHF SE Major BanksFinance ODDO BHF SE provides banking and financial services. It specializes in private banking, asset management, as well as corporate and investment banking. The company was founded in 1854 and is headquartered in Frankfurt, Germany. | Major Banks | Chief Executive Officer | |
Mainstay Medical Holdings Plc
Mainstay Medical Holdings Plc Financial ConglomeratesFinance Mainstay Medical Holdings Plc is a medical device company, which focuses on commercializing an innovative implantable restorative neurostimulation system, ReActiv8, for people with disabling mechanical Chronic Low Back Pain. The company was founded in 2020 and is headquartered in Dublin, Ireland. | Financial Conglomerates | Director/Board Member | |
MAINSTAY MEDICAL INTERNATIONAL | Medical Specialties | Director/Board Member | |
Life Sciences Acceleration Alliance eV | Director/Board Member | ||
OLMIX | Chemicals: Agricultural | Founder | |
Amadéite SAS
Amadéite SAS Food: Specialty/CandyConsumer Non-Durables Amadéite SAS manufactures and wholesales additives and food flavorings. It offers services to the food sectors. The company was founded on June 12, 1995 and is headquartered in Brehan, France. | Food: Specialty/Candy | Chief Executive Officer | |
Amadéite
Amadéite Financial ConglomeratesFinance Amadéite is an investment holding private company based in Brehan, France. Amadéite functions as an investment holding French company. The CEO of the company is Hervé Balusson. | Financial Conglomerates | Chief Executive Officer | |
Bio-Sourcing SA
Bio-Sourcing SA BiotechnologyHealth Technology Bio-Sourcing SA develops and markets biological drugs for veterinary use. The firm focuses on farm animal health and companion animal health. The company was founded by Bertrand Mérot in June 2011 and is headquartered in Liege, Belgium. | Biotechnology | Founder | |
Keosys SAS
Keosys SAS Medical/Nursing ServicesHealth Services Keosys SAS specializes in imaging and communication systems for nuclear medicine and radiology. It engages in medical imaging, telecommunication and information technology services. The firm develops products and services for medical diagnosis and clinical trials. The company was founded in 2001 and is headquartered in Saint-Herblain, France. | Medical/Nursing Services | Chief Executive Officer | |
Inserm-Transfert SA
Inserm-Transfert SA Miscellaneous Commercial ServicesCommercial Services Inserm-Transfert SA engages in the managements of economic and societal value creation and the transfer of knowledge. It operates in the human health innovation sector. The company was founded in 2000 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member |
Statistics
International
France | 41 |
Belgium | 5 |
United States | 3 |
Germany | 3 |
Sweden | 2 |
Sectoral
Health Technology | 23 |
Finance | 10 |
Commercial Services | 8 |
Consumer Services | 5 |
Process Industries | 4 |
Operational
Director/Board Member | 180 |
Chairman | 60 |
Corporate Officer/Principal | 53 |
Chief Executive Officer | 52 |
Founder | 39 |
Most connected contacts
Insiders | |
---|---|
Franck Lescure | 28 |
Damian Marron | 23 |
Franck Grimaud | 22 |
Gilles Alberici | 18 |
Marc Le Bozec | 16 |
Michel Finance | 15 |
Maryvonne Hiance | 15 |
Sacha Loiseau | 15 |
Cédric Moreau | 14 |
Loïc Maurel | 12 |
Enrico Jose Adolfo Bastianelli | 11 |
Gilles Avenard | 11 |
Christian Policard | 10 |
Christian Béchon | 10 |
Renaud Vaillant | 10 |
- Stock Market
- Insiders
- Jean-Marc Ferrier
- Company connections